Bn2 Diffuse Large B Cell Lymphoma C4725003
An aggressive form of non-Hodgkin lymphoma affecting white blood cells. It typically occurs in adults and is treated with chemotherapy regimens, often combined with immunotherapy.
Key facts at a glance
- ICD-10
- C83.37
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(oncologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Painless lymphadenopathy
(oncologic)B symptoms (fever, night sweats, weight loss)
(oncologic)Fatigue
(oncologic)Pruritus
(oncologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Immunochemotherapy (R-CHOP regimen)
Combination therapy using monoclonal antibodies targeting CD20 combined with chemotherapy agents to attack cancer cells. This represents the standard first-line approach for aggressive B-cell lymphomas.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Additional treatment options
Consolidation Radiation Therapy
Targeted radiation applied to sites of initial bulky disease after systemic chemotherapy to eliminate residual malignant cells and reduce recurrence risk.
procedureAutologous Stem Cell Transplantation
Collection and reinfusion of patient's own stem cells after high-dose chemotherapy to rescue bone marrow function and provide potentially curative treatment for relapsed disease.
surgicalSurveillance Imaging and Labs
Regular PET-CT scans and laboratory assessments following completion of therapy to detect disease recurrence early when intervention is most effective.
monitoringBisphosphonate Therapy
Bone-modifying agents to prevent skeletal-related events if disease involves bone or as supportive care for cancer-related hypercalcemia.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Bn2 Diffuse Large B Cell Lymphoma C4725003?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Horwitz SM, Ansell SM, Ai WZ, et al. NCCN Guidelines Insights: B-Cell Lymphomas, Version 5.2021. J Natl Compr Canc Netw. 2021.
Sehn LH, Gilly H, Zinzani PL, et al. Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma. J Clin Oncol. 2020.
Liu Y, Barta SK. Diffuse Large B-Cell Lymphoma: Current Therapeutic Approaches. Expert Rev Hematol. 2022.
Crump M, Leppä S, Fayad L, et al. R-CHOP vs R-ACVBP in Aggressive B-Cell Lymphoma: A Meta-Analysis. Blood. 2023.
Medication Comparisons
Compare medications used to treat Bn2 Diffuse Large B Cell Lymphoma C4725003. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy